6月18日中银创新医疗混合A净值增长0.64%，今年来累计上涨57.01%

Core Insights - The latest net value of Zhongyin Innovation Medical Mixed A Fund (007718) is 1.8893 CNY, with a growth of 0.64% [1] - The fund has shown a one-month return of 16.39%, ranking 76 out of 4640 in its category; a six-month return of 50.83%, ranking 25 out of 4486; and a year-to-date return of 57.01%, ranking 24 out of 4506 [1] Fund Holdings - The top ten stock holdings of Zhongyin Innovation Medical Mixed A Fund account for a total of 70.44%, with the largest positions being: - Kelun-Botai (9.77%) - Heng Rui Pharmaceutical (9.39%) - Innovent Biologics (8.54%) - CanSino Biologics (8.24%) - CanSino-B (6.59%) - New Horizon Health (6.27%) - BeiGene-U (6.02%) - Baillie Gifford (5.89%) - Hutchison China MediTech (5.16%) - Hansoh Pharmaceutical (4.57%) [1] Fund Management - Zhongyin Innovation Medical Mixed A Fund was established on November 13, 2019, and as of March 31, 2025, it has a total asset size of 2.613 billion CNY [1] - The fund manager is Zheng Ning, who has a background in stock research and has held positions at various asset management companies before joining Zhongyin Fund Management in 2022 [2]